Citric Acid → [(S)-2-(4-Benzyloxy-phenyl)-1-((2S,4R)-4-methyl-5-oxo-tetrahydro-furan-2-yl)-ethyl]-carbamic acid tert-butyl ester
Reaction equation
[C:1]([O:5][C:6](=[O:30])[NH:7][C@H:8]([C@@H:24]1[CH2:28][CH2:27][C:26](=[O:29])[O:25]1)[CH2:9][C:10]1[CH:15]=[CH:14][C:13]([O:16][CH2:17][C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=2)=[CH:12][CH:11]=1)([CH3:4])([CH3:3])[CH3:2].[CH3:31]N1C(=O)N(C)CCC1.C[Si](C)(C)[N-][Si](C)(C)C.[Li+].CI.C(O)(=O)CC.C(O)(=O)CC(CC(O)=O)(C(O)=O)O>C1COCC1.O>[C:1]([O:5][C:6](=[O:30])[NH:7][C@H:8]([C@@H:24]1[CH2:28][C@@H:27]([CH3:31])[C:26](=[O:29])[O:25]1)[CH2:9][C:10]1[CH:11]=[CH:12][C:13]([O:16][CH2:17][C:18]2[CH:19]=[CH:20][CH:21]=[CH:22][CH:23]=2)=[CH:14][CH:15]=1)([CH3:4])([CH3:2])[CH3:3]Participants
Reactant 6
Product 1
Reagents, catalysts & solvents 2
Procedure
[(S)-2-(4-Benzyloxy-phenyl)-1-((S)-5-oxo-tetrahydro-furan-2-yl)-ethyl]-carbamic acid tert-butyl ester (2.9 g, 7.04 mmol) is dissolved in THF (10 ml) and DMPU (1.34 ml, 10.6 mmol, 1.5 eq). A 1 M solution of lithium hexamethyldisilazide in THF (14.1 ml, 14.1 mmol, 2 eq) is added at −78° C. over 40 min and the mixture is stirred for another 20 min. Methyliodide (0.88 ml, 14.1 mmol, 2 eq) is added dropwise and the mixture is stirred for another 3 h at −78° C. before adding propionic acid (2.69 ml, 36 mmol, 5 eq) and water. After warming up to rt the mixture is poured on 10% citric acid (50 ml) and extracted with EtOAc. The organic layer is washed with bicarbonate and brine, dried over magnesium sulfate and evaporated. The crude product is purified by chromatography on silica (hexane/EtOAc 8/2 to 7/3) followed by recrystallization from hexane/DCM to give 2.2 g white solid.
Workup
- stirringthe mixture is stirred for another 3 h at −78° C.
- extractionextracted with EtOAc
- washThe organic layer is washed with bicarbonate and brine
- dry with materialdried over magnesium sulfate
- customevaporated
- customThe crude product is purified by chromatography on silica (hexane/EtOAc 8/2 to 7/3)
- customfollowed by recrystallization from hexane/DCM
Sources & evidence
- ORD record
- ord-ff85f98762d145f5837296ab64e6291a
- Source dataset
- uspto-grants-2009_11
- Patent number
- US07612054B2
Reaction notes
Loading…